HEADER LIPASE 01-AUG-05 2BYF TITLE NMR SOLUTION STRUCTURE OF PHOSPHOLIPASE C EPSILON RA 2 DOMAIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: PHOSPHOLIPASE C, EPSILON 1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RA2 DOMAIN, RESIDUES 2131-2246; COMPND 5 SYNONYM: PHOSPHOLIPASE C EPSILON; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_VARIANT: C41; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PTRIEX4 KEYWDS PHOSPHOLIPASE C EPSILON, RAS BINDING DOMAIN, UBIQUITIN SUPERFOLD, KEYWDS 2 LIPASE EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR T.D.BUNNEY,R.HARRIS,N.L.GANDARILLAS,M.B.JOSEPHS,S.M.ROE,H.F.PATERSON, AUTHOR 2 F.RODRIGUES-LIMA,D.ESPOSITO,P.GIESCHIK,L.H.PEARL,P.C.DRISCOLL, AUTHOR 3 M.KATAN REVDAT 5 14-JUN-23 2BYF 1 REMARK REVDAT 4 15-JAN-20 2BYF 1 REMARK REVDAT 3 24-JAN-18 2BYF 1 SOURCE REVDAT 2 24-FEB-09 2BYF 1 VERSN REVDAT 1 22-FEB-06 2BYF 0 JRNL AUTH T.D.BUNNEY,R.HARRIS,N.L.GANDARILLAS,M.B.JOSEPHS,S.M.ROE, JRNL AUTH 2 S.C.SORLI,H.F.PATERSON,F.RODRIGUES-LIMA,D.ESPOSITO, JRNL AUTH 3 C.P.PONTING,P.GIERSCHIK,L.H.PEARL,P.C.DRISCOLL,M.KATAN JRNL TITL STRUCTURAL AND MECHANISTIC INSIGHTS INTO RAS ASSOCIATION JRNL TITL 2 DOMAINS OF PHOSPHOLIPASE C EPSILON. JRNL REF MOL.CELL V. 21 495 2006 JRNL REFN ISSN 1097-2765 JRNL PMID 16483931 JRNL DOI 10.1016/J.MOLCEL.2006.01.008 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : XPLOR-NIH REMARK 3 AUTHORS : C.D. SCHWIETERS, J.J. KUSZEWSKI, N. TJ REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: AB INITIO SIMULATED ANNEALING PROTOCOL REMARK 3 WITH CARTESIAN MOLECULAR DYNAMICS AND TORSION ANGLE DYNAMICS REMARK 3 SIMULATED ANNEALING. A FINAL STEP OF RESTRAINED MOLECULAR REMARK 3 DYNAMICS WITH EXPLICIT INCLUSION OF SOLVENT. REMARK 4 REMARK 4 2BYF COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 01-AUG-05. REMARK 100 THE DEPOSITION ID IS D_1290025142. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298.0; 298.0 REMARK 210 PH : 6.5; 6.5 REMARK 210 IONIC STRENGTH : 275; 275 REMARK 210 PRESSURE : 1.0 ATM; 1.0 ATM REMARK 210 SAMPLE CONTENTS : 90% WATER, 10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : C13-NOESY; N15-NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ; 600 MHZ REMARK 210 SPECTROMETER MODEL : INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : ANSIG, CNS, XPLOR-NIH REMARK 210 METHOD USED : RESTRAINED SIMULATED ANNEALING, REMARK 210 WATER REFINEMENT REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : LOWEST ENERGY STRUCTURE WITH NO REMARK 210 RESTRAINT VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: THE STRUCTURE WAS DETERMINED USING TRIPLE-RESONANCE NMR REMARK 210 SPECTROSCOPY ON 13C, 15N-LABELED PROTEIN. REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, ARG 2150 TO LEU REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HD12 LEU A 59 HB3 PHE A 101 1.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 SER A 2 -160.48 179.37 REMARK 500 1 GLU A 17 94.20 61.43 REMARK 500 1 GLN A 18 76.52 66.33 REMARK 500 1 TYR A 44 -12.32 70.70 REMARK 500 1 SER A 45 -74.73 -54.72 REMARK 500 1 ASP A 66 -173.84 -60.77 REMARK 500 1 ASN A 69 -152.37 -87.02 REMARK 500 1 CYS A 87 121.52 68.02 REMARK 500 1 GLN A 110 89.82 -50.73 REMARK 500 1 ALA A 111 18.04 -154.27 REMARK 500 1 SER A 112 60.61 -104.81 REMARK 500 1 ARG A 113 -92.53 60.31 REMARK 500 2 SER A 45 -70.43 -64.26 REMARK 500 2 SER A 47 92.13 59.37 REMARK 500 2 LEU A 49 34.63 -84.05 REMARK 500 2 ASP A 66 -97.86 -71.02 REMARK 500 2 THR A 67 88.78 -157.92 REMARK 500 2 ASN A 69 -85.26 -120.79 REMARK 500 2 LYS A 70 -142.70 -128.73 REMARK 500 2 THR A 73 -117.95 51.40 REMARK 500 2 CYS A 87 106.73 68.44 REMARK 500 3 PRO A 16 -144.58 -73.81 REMARK 500 3 GLU A 17 -64.26 71.66 REMARK 500 3 TYR A 44 -43.45 68.42 REMARK 500 3 VAL A 64 105.21 -59.17 REMARK 500 3 ASN A 69 -89.38 54.63 REMARK 500 3 THR A 72 96.71 -67.46 REMARK 500 3 CYS A 87 122.04 73.21 REMARK 500 3 GLU A 114 -71.35 67.14 REMARK 500 4 GLU A 4 114.77 -35.45 REMARK 500 4 PRO A 16 -159.31 -74.50 REMARK 500 4 GLU A 17 -60.51 71.22 REMARK 500 4 TYR A 44 -35.40 74.51 REMARK 500 4 SER A 47 60.95 37.63 REMARK 500 4 LYS A 71 -49.89 72.38 REMARK 500 4 THR A 73 97.83 68.10 REMARK 500 4 CYS A 87 130.49 70.21 REMARK 500 4 GLN A 110 85.40 -56.66 REMARK 500 5 GLU A 17 -56.67 72.93 REMARK 500 5 TYR A 44 -126.66 62.77 REMARK 500 5 SER A 45 -87.57 64.83 REMARK 500 5 SER A 47 78.58 51.46 REMARK 500 5 THR A 68 -85.95 60.07 REMARK 500 5 LEU A 83 -51.68 -131.93 REMARK 500 5 ASP A 84 -38.36 177.34 REMARK 500 5 CYS A 87 96.26 67.84 REMARK 500 5 SER A 112 -168.53 -105.26 REMARK 500 6 ALA A 42 44.99 -81.09 REMARK 500 6 SER A 45 -81.43 -52.80 REMARK 500 6 ASN A 51 68.69 65.66 REMARK 500 REMARK 500 THIS ENTRY HAS 186 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2BYE RELATED DB: PDB REMARK 900 NMR SOLUTION STRUCTURE OF PHOSPHOLIPASE C EPSILON RA 1 DOMAIN REMARK 900 RELATED ID: 6635 RELATED DB: BMRB DBREF 2BYF A 1 116 UNP Q5VWL5 Q5VWL5_HUMAN 2131 2246 SEQADV 2BYF LEU A 20 UNP Q5VWL5 ARG 2150 ENGINEERED MUTATION SEQRES 1 A 116 SER SER GLU GLU GLU SER PHE PHE VAL GLN VAL HIS ASP SEQRES 2 A 116 VAL SER PRO GLU GLN PRO LEU THR VAL ILE LYS ALA PRO SEQRES 3 A 116 ARG VAL SER THR ALA GLN ASP VAL ILE GLN GLN THR LEU SEQRES 4 A 116 CYS LYS ALA LYS TYR SER TYR SER ILE LEU SER ASN PRO SEQRES 5 A 116 ASN PRO SER ASP TYR VAL LEU LEU GLU GLU VAL VAL LYS SEQRES 6 A 116 ASP THR THR ASN LYS LYS THR THR THR PRO LYS SER SER SEQRES 7 A 116 GLN ARG VAL LEU LEU ASP GLN GLU CYS VAL PHE GLN ALA SEQRES 8 A 116 GLN SER LYS TRP LYS GLY ALA GLY LYS PHE ILE LEU LYS SEQRES 9 A 116 LEU LYS GLU GLN VAL GLN ALA SER ARG GLU ASP LYS HELIX 1 1 THR A 30 ALA A 42 1 13 HELIX 2 2 SER A 47 ASN A 51 5 5 HELIX 3 3 ASN A 53 SER A 55 5 3 HELIX 4 4 CYS A 87 TRP A 95 1 9 SHEET 1 AA 5 LEU A 20 PRO A 26 0 SHEET 2 AA 5 SER A 6 HIS A 12 -1 O PHE A 7 N ALA A 25 SHEET 3 AA 5 LYS A 100 LEU A 105 1 O PHE A 101 N HIS A 12 SHEET 4 AA 5 TYR A 57 VAL A 64 -1 O VAL A 58 N LYS A 104 SHEET 5 AA 5 SER A 77 VAL A 81 -1 O SER A 78 N VAL A 63 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1